Partnervest Advisory Services’s Novo Nordisk NVO Stock Holding History

Partnervest Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-740	Closed	-$17K	–	586
2014 Q2	$17K	Hold	740	–	–	0.01%	575
2014 Q1	$17K	Hold	740	–	–	0.01%	546
2013 Q4	$14K	Sell	740 -750	-50%	-$13.1K	0.01%	567
2013 Q3	$25K	Hold	1,490	–	–	0.01%	404
2013 Q2	$23K	Buy	+1,490	New	+$24.8K	0.01%	389

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Partnervest Advisory Services's NVO Position: Q3 2014 in Review

Partnervest Advisory Services sold out of Novo Nordisk (NVO) in Q3 2014, closing a stake of 740 shares — an estimated $17K sold.

Partnervest Advisory Services first reported a position in NVO in Q2 2013 and held it in 5 quarters. The position peaked at $25K in Q3 2013. 469 funds tracked by Wall St. Rank hold NVO as of Q3 2014.

Partnervest Advisory Services reported no remaining Novo Nordisk position as of Q3 2014 after selling out during the quarter.
Partnervest Advisory Services sold 740 Novo Nordisk shares in Q3 2014, an estimated $17K.
Partnervest Advisory Services first reported a position in Novo Nordisk in Q2 2013 and held it in 5 quarters.
Partnervest Advisory Services's Novo Nordisk position peaked at $25K in Q3 2013.
469 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2014.

Based on Partnervest Advisory Services's 13F filing for Q3 2014, filed 7 Nov 2014.